Proper functioning of the nervous system requires highly ordered and tightly regulated synapse formation. The long-range goal of this project is to elucidate the molecular and cellular mechanisms that underlie postsynaptic differentiation. Agrin is an extracellular matrix protein that induces the clustering of acetylcholine receptors (AChRs) on myotubes in culture. At developing neuromuscular junctions in vivo, agrin is likely to direct the assembly of key elements of the postsynaptic apparatus. Agrin mRNA is alternatively spliced yielding agrin isoforms that have large differences in AChR clustering potency. During the previous funding period, a candidate agrin receptor from Torpedo electric organ postsynaptic membranes was identified and was shown to be a heteromeric complex whose subunits are homologous to alpha- and beta- dystroglycan. Preliminary experiments using alternatively-spliced agrin isoforms have indicated that myotubes and postsynaptic membranes express several classes of agrin receptors, each of which contains alpha-dystroglycan. The proposed experiments are designed to characterize these newly recognized classes of agrin receptors at the cellular, biochemical, and molecular levels. The first goal (Specific Aims #1 and #2) is to analyze agrin- isoform selective receptors at the cellular and biochemical levels. It is hypothesized that the different classes of agrin receptors perform distinct but interrelated roles during synapse development. The experiments in Specific Aim #3, are designed to establish the developmental profile of the expression of these agrin receptor classes, to localize them at synapses in vivo, and to study their regulation during key stages in nerve-muscle synaptogenesis. Further, it is hypothesized that other proteins that associate with the dystroglycans play important roles in mediating agrin's actions. Experiments in Specific Aim #4 are designed to characterize and to clone one such protein, a novel dystroglycan/dystrophin- associated protein discovered in this laboratory. The results of these studies will provide vital insights into the means by which synaptic differentiation proceeds during development and regeneration. In addition, the experiments proposed here focus on the dystroglycans, part of a protein complex that is defective in several muscular dystrophies. Knowledge of the function of this complex, and the factors that mediate its assembly, could provide new keys to understanding and eventually treating these diseases.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD023924-12
Application #
2888959
Study Section
Neurology B Subcommittee 2 (NEUB)
Program Officer
Henken, Deborah B
Project Start
1988-08-01
Project End
2001-02-28
Budget Start
1999-04-01
Budget End
2001-02-28
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brown University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912
Fallon, Justin R; McNally, Elizabeth M (2018) Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics. Matrix Biol 68-69:616-627
Yilmaz, Atilgan; Kattamuri, Chandramohan; Ozdeslik, Rana N et al. (2016) MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells. Sci Signal 9:ra87
Young, Marian F; Fallon, Justin R (2012) Biglycan: a promising new therapeutic for neuromuscular and musculoskeletal diseases. Curr Opin Genet Dev 22:398-400
Amenta, Alison R; Creely, Hilliary E; Mercado, Mary Lynn T et al. (2012) Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci 32:2324-34
Amenta, Alison R; Yilmaz, Atilgan; Bogdanovich, Sasha et al. (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A 108:762-7
Fallon, Justin R (2011) Calcium channels put synapses in their place. Nat Neurosci 14:536-8
Peat, Rachel A; Gecz, Jozef; Fallon, Justin R et al. (2008) Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders. Neuromuscul Disord 18:606-9
Mercado, Mary Lynn; Amenta, Alison R; Hagiwara, Hiroki et al. (2006) Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J 20:1724-6
Campagna, J A; Fallon, J (2006) Lipid rafts are involved in C95 (4,8) agrin fragment-induced acetylcholine receptor clustering. Neuroscience 138:123-32
Rafii, Michael S; Hagiwara, Hiroki; Mercado, Mary Lynn et al. (2006) Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol 209:439-47

Showing the most recent 10 out of 29 publications